Skip to main content
GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
15.09
+0.30 (2.03%)
At close: Nov 20, 2024, 4:00 PM
15.45
+0.36 (2.39%)
Pre-market: Nov 21, 2024, 7:40 AM EST

GRAIL Revenue

GRAIL had revenue of $28.65M in the quarter ending September 30, 2024, with 27.83% growth. This brings the company's revenue in the last twelve months to $117.67M, up 111.83% year-over-year. In the year 2023, GRAIL had annual revenue of $93.11M with 67.61% growth.

Revenue (ttm)
$117.67M
Revenue Growth
+111.83%
P/S Ratio
4.26
Revenue / Employee
$86,521
Employees
1,360
Market Cap
507.04M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202393.11M37.56M67.61%
Jan 1, 202355.55M40.94M280.17%
Jan 2, 202214.61M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Y-mAbs Therapeutics 84.55M
Theravance Biopharma 63.19M
Cartesian Therapeutics 47.94M
MeiraGTx Holdings 13.93M
Taysha Gene Therapies 9.92M
Perspective Therapeutics 1.56M
Revenue Rankings

GRAL News

More News